The influence of semen-derived enhancer of virus infection on the efficiency of retroviral gene transfer

Journal of Gene Medicine

Volumn 12, Issue 2, 2010, Pages 137-146

  Wurm, Melanie ^a   Schambach, Axel ^a   Lindemann, Dirk ^b   Hanenberg, Helmut ^c,d   Ständker, Ludger ^a   Forssmann, Wolf Georg ^a   Blasczyk, Rainer ^a   Horn, Peter A ^e  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d RILEY HOSPITAL FOR CHILDREN   (United States)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Gene therapy; Retroviral gene transfer; SEVI; Transduction efficiency

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; HEXADIMETHRINE BROMIDE; LENTIVIRUS VECTOR; PEPTIDE; PROTAMINE SULFATE; RETROVIRUS VECTOR; SEMEN DERIVED ENHANCER OF VIRUS INFECTION; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CELL STRAIN K 562; CONTROLLED STUDY; EMBRYO; GENE TRANSFER; GENETIC TRANSDUCTION; HELA CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOTYPING; RETROVIRUS; SPERM; VIRUS ATTACHMENT; VIRUS INFECTIVITY;

GIBBON APE LEUKEMIA VIRUS; LENTIVIRUS; MURINAE; VESICULAR STOMATITIS VIRUS;

EID: 76049129479     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1429     Document Type: Article

References (31)

1. Aiuti A, Cattaneo F, Galimberti S, et al. Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med 2009; 360: 447-458.
2. Beard BC, Keyser KA, Trobridge GD, et al. Unique integration profiles in a canine model of long-term repopulating cells transduced with gammaretrovirus, lentivirus, or foamy virus. Hum Gene Ther 2007; 18: 423-434.
3. Cavazzana-Calvo M, Hacein-Bey-Abina S, Fischer A. Gene therapy of X-linked severe combined immunodeficiency. Curr Opin Allergy Clin Immunol 2002; 2: 507-509.
4. Hacein-Bey-Abina S, Le Deist F, Carlier F, et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 2002; 346: 1185-1193.
5. Relander T, Johansson M, Olsson K, et al. Gene transfer to repopulating human CD34+ cells using amphotropic-, GALV-, or RD114-pseudotyped HIV-1-based vectors from stable producer cells. Mol Ther 2005; 11: 452-459.
6. Kiem HP, Allen J, Trobridge G, et al. Foamy-virus-mediated gene transfer to canine repopulating cells. Blood 2007; 109: 65-70.
7. Burns JC, Friedmann T, Driever W, et al. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci USA 1993; 90: 8033-8037.
8. Yang J, Friedman MS, Bian H, et al. Highly efficient genetic transduction of primary human synoviocytes with concentrated retroviral supernatant. Arthritis Res 2002; 4: 215-219.
9. Hanenberg H, Xiao XL, Dilloo D, et al. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nat Med 1996; 2: 876-882.
10. Hanenberg H, Hashino K, Konishi H, et al. Optimization of fibronectin-assisted retroviral gene transfer into human CD34+ hematopoietic cells. Hum Gene Ther 1997; 8: 2193-2206.
11. Cornetta K, Anderson WF. Protamine sulfate as an effective alternative to polybrene in retroviral-mediated gene-transfer: implications for human gene therapy. J Virol Methods 1989; 23: 187-194.
12. Seitz B, Moreira L, Baktanian E, et al. Retroviral vector-mediated gene transfer into keratocytes in vitro and in vivo. Am J Ophthalmol 1998; 126: 630-639.
13. Coelen R, Jose D, May J. The effect of hexadimethrine bromide (polybrene) on the infection of primate retroviruses SSV1/SSAV1 and BaEV. Arch Virol 1983; 75: 307-311.
14. Swaney WP, Sorgi FL, Bahnson AB, et al. The effect of cationic liposome pretreatment and centrifugation on retrovirus-mediated gene transfer. Gene Ther 1997; 4: 1379-1386.
15. Porter CD, Lukacs KV, Box G, et al. Cationic liposomes enhance the rate of transduction by a recombinant retroviral vector in vitro and in vivo. J Virol 1998; 72: 4832-4840.
16. Sakoda T, Kasahara N, Kedes L, et al. Calcium phosphate coprecipitation greatly enhances transduction of cardiac myocytes and vascular smooth muscle cells by lentivirus vectors. Exp Clin Cardiol 2007; 12: 133-138.
17. Munch J, Rucker E, Standker L, et al. Semen-derived amyloid fibrils drastically enhance HIV infection. Cell 2007; 131: 1059-1071.
18. Royce RA, Sena A, Cates W Jr, et al. Sexual transmission of HIV. N Engl J Med 1997; 336: 1072-1078.
19. Roan NR, Munch J, Arhel N, et al. The cationic properties of SEVI underlie its ability to markedly enhance HIV infection. J Virol 2009; 83: 73-80.
20. Schambach A, Mueller D, Galla M, et al. Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors. Gene Ther 2006; 13: 1524-1533.
21. Cosset FL, Takeuchi Y, Battini JL, et al.High-titer packaging cells producing recombinant retroviruses resistant to human serum. J Virol 1995; 69: 7430-7436.
22. Stitz J, Buchholz CJ, Engelstadter M, et al. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1. Virology 2000; 273: 16-20.
23. Fields GB, Noble RL. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int J Pept Protein Res 1990; 35: 161-214.
24. Miller AD, Chen F. Retrovirus packaging cells based on 10A1 murine leukemia virus for production of vectors that use multiple receptors for cell entry. J Virol 1996; 70: 5564-5571.
25. Rasko JE, Battini JL, Gottschalk RJ, et al. The RD114/simian type D retrovirus receptor is a neutral amino acid transporter. Proc Natl Acad Sci USA 1999; 96: 2129-2134.
26. Logan AC, Nightingale SJ, Haas DL, et al. Factors influencing the titer and infectivity of lentiviral vectors. Hum Gene Ther 2004; 15: 976-988.
27. Clark PR, Stopeck AT, Brailey JL, et al. Polycations and cationic lipids enhance adenovirus transduction and transgene expression in tumor cells. Cancer Gene Ther 1999; 6: 437-446.
28. Lee H, Song JJ, Kim E, et al. Efficient gene transfer of VSV-G pseudotyped retroviral vector to human brain tumor. Gene Ther 2001; 8: 268-273.
29. Dybing J, Lynch CM, Hara P, et al. GaLV pseudotyped vectors and cationic lipids transduce human CD34+ cells. Hum Gene Ther 1997; 8: 1685-1694.
30. Flasshove M, Banerjee D, Mineishi S, et al. Ex vivo expansion and selection of human CD34+ peripheral blood progenitor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene transfer. Blood 1995; 85: 566-574.
31. Gaspar HB, Parsley KL, Howe S, et al. Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet 2004; 364: 2181-2187.